Bio Thera Solutionsltdis A Biopharmaceutical Company Based In Guangzhouchinathe Company Focuses On Researchingdevelopingmanufacturingand Delivering Novel And Biosimilar Therapeutics For Cancerautoimmune Diseasescardiovascular Diseasesand Other Serious Medical Needsbio Thera Is Listed On The Shanghai Stock Exchange Under The Ticker Symbol 688177 Sh The Company S Mission Is To Improve Patient Well Being By Providing Safeeffectiveand Affordable Medicinal Productsbio Thera Aims To Become A Leading Global Biopharmaceutical Company By Developing And Commercializing Biosimilars And Best In Class Biologicstheir Product Pipeline Includes Several Biosimilar Candidatessuch As Bat1406Bat1706And Bat1806As Well As Novel Drug Candidates Like Bat2094Bio Thera Has Also Partnered With Stada For The Commercialization Of Bat2506A Biosimilar Candidatewith A Workforce Of Approximately 1 167 Employeesthe Company Has Experienced Significant Growth In Biopharmaceutical Salesreaching 705 Million Cny In 2023
